Skip to content
OpenCapital
Get started

Trueblue TBI Concentration Risk %

Concentration Risk % at other companies

Identive logo
IdentiveINVE
10.3%+7.7pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp

Segments

By segment

See full
PeopleScout17.3%—

Other financials

Income statement

See full
Revenue$398.6M+7.6%
Gross profit$79.0M-8.5%
Operating income-$17.8M-26.4%
Net income-$19.8M-38.0%
EPS (diluted)-$0.66-37.5%

Balance sheet

See full
Cash & equivalents$24.1M+4.7%
Total debt$130.4M+13.2%
Total equity$256.1M-15.3%
Total assets$620.7M-10.4%

Cash flow

See full
Operating cash flow-$9.8M+55.8%
CapEx$2.8M-39.6%
Free cash flow-$12.6M+52.9%

Valuation

See full
Market cap$205.23M+4.8%
Enterprise value$311.53M+9.7%
P/S0.1×0.0×

Profitability

See full
Gross margin21.9%-3.7pp
Operating margin-3.1%-1.0pp
Net margin-3.2%-1.3pp
FCF margin-3.6%+0.8pp

Returns & leverage

See full
Return on equity-19.1%-6.2pp
Debt / equity0.5×+0.1×
Current ratio2.1×+0.3×